Katharine Cheung, M.D., Ph.D., assistant professor of medicine, assumed the role of Interim Director of the Center on Aging, effective September 1. A geriatric and palliative nephrologist, Cheung served on the center’s advisory board from 2017-2023. As interim director, Cheung's top priorities include relaunching pilot grants for faculty who are interested in pursuing research focused on gerontology or geriatric issues.

Andra Stevenson, Ph.D.’01, Returns to UVM to Share Insights on Mentorship and Career Journey

The University of Vermont and UVM Larner College of Medicine are delighted to announce the upcoming "Dean's Celebration of Excellence in Research," a weeklong celebration dedicated to showcasing the exceptional research endeavors of faculty, research fellows, and graduate students. Held September 18 to 22, 2023, this year’s series promises to be an extraordinary platform for academic discovery and collaboration.

Cliff Reilly '24 aspires to work at a small community hospital in Vermont. As the inaugural recipient of an incentive scholarship that will pay back his medical school loans, this goal is within Reilly's grasp. The incentive aims to strengthen the physician workforce pipeline into Vermont, as the state competes nationally and globally to attract and retain a geographically distributed physician workforce.

Anne Dixon, M.A, B.M.B.Ch., Professor of Medicine, has been appointed Chair of the Department of Medicine in the Larner College of Medicine at the University of Vermont.

Earlier this year, the University of Vermont Medical Center’s STOP THE BLEED® Program celebrated its five-year anniversary. Since 2018, more than 5,500 Vermont citizens have received life-saving training to stop bleeding in traumatic scenarios.

Emmett Whitaker, M.D., FAAP, associate professor of anesthesiology, neurological sciences, and pediatrics, received a substantial R35 MIRA grant from NIGMS for his study “Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age.” This five-year project—the department’s first NIH grant—addresses intraoperative hypotension in neonates, infants, and older adults under anesthesia.

In 2021, University of Vermont neuroscientists received a $5.5 million National Institute of Health (NIH) grant to support the Phase II segment of the HEALthy Brain and Child Development (HBCD) Study. The HBCD Study, the largest long-term study of early brain and child development in the United States, aims to comprehensively collect data on brain development from birth through early childhood, shedding light on the factors that shape a young person's life trajectory.

The Division of Dermatology welcomed Mary Maloney, M.D., to the faculty this spring, for the second time. A medical alum from the University of Vermont class of 1977, Maloney is an expert Mohs surgeon. This procedure, which was relatively new when Maloney began her career as a physician, involves removing skin cancer in layers, looking at the skin under a microscope while the patient waits, then removing more layers as necessary. Maloney was Vermont's first and only Mohs surgeon when she served on the UVM faculty from 1983-88, and the second female Mohs surgeon in the U.S.

Kristin Flanary, known internationally as her social media alter ego, Lady Glaucomflecken, is on a mission to make health care a little more human. Through storytelling, her keynote address on September 29 at the Women’s Health and Cancer Conference will highlight her perspective as a caregiver and “co-survivor” of her husband’s two cancer occurrences and sudden cardiac arrest.